Par Nijhawan

Par Nijhawan has a diverse work experience in the biotech and healthcare industry. In 2002, they founded Medical Futures and served as the CEO and Founder until 2015. Subsequently, in 2005, they founded the Digestive Health Clinic. In 2015, Par founded Edesa Biotech and became the CEO and Founder. Par also founded Exzell Pharma in 2015 but left the company in August 2022.

Par Nijhawan has a diverse education history in the field of medicine and pharmacy. Par attended the Mayo Clinic Alix School of Medicine, where they studied Internal Medicine, Gastroenterology, and Hepatology. The precise years of study are not provided. Additionally, Par completed an Internship at Yale University. Again, the specific duration of this program is unknown. Prior to these experiences, Par obtained a Doctor of Medicine (MD) degree from the University of Ottawa. No specific years of study are mentioned for this degree. Lastly, Par pursued studies in Pharmacy at the University of Toronto, although the timeframe for this education is unspecified as well.